Does trait mindfulness level affect quitting cannabis use? A six week follow-up study

Paltun, Salih Cihat; Altunsoy, Neslihan; Özdemir, Sinem Duran; Okay, Ihsan Tuncer

doi:10.1590/0101-60830000000139

Acessibilidade / Reportar erro

Brasil

Archives of Clinical Psychiatry (São Paulo)

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Article • Arc. Clin. Psychiatr. 44 (6) • Nov-Dec 2017 • https://doi.org/10.1590/0101-60830000000139 copy

Does trait mindfulness level affect quitting cannabis use? A six week follow-up study

Authorship SCIMAGO INSTITUTIONS RANKINGS

Abstract

Background:

Only 29% of cannabis dependent individuals seek treatment, yet significant decreases in cannabis use are seen in 31-36% of individuals that seek treatment. Follow-up studies have found that over 60% in substance use disorders end in relapse, leading to potentially chronic and relapsing cases. New and effective therapies should be researched in order to increase the success of relapse prevention treatments.

Objective:

In this study we aimed to evaluate the relationship between trait mindfulness level, substance dependence severity and quitting cannabis use.

Methods:

A hundred and sixty four patients, diagnosed with cannabis dependence, were involved in the study; socidemographic datas were recorded and Addiction Profile Index (API), Mindfuness Attention and Awareness Scale (MAAS) were carried out.

Results:

We found that the trait mindfulness level is significantly related with quitting cannabis use.

Discussion:

Trait mindfulness may be an important determining factor of the ability to quit substance use and achieve remission.

Keywords:
Dependence; mindfulness; cannabis

	Group Continue (n = 79)	Group Quit (n = 85)	^p* p* p value obtained bay applying chi-square test.
I have lived legal problems depending on cannabis use	14 (17.7%)	5 (5.9%)	0.034
Cannabis use is a problem in my life	52 (65.8%)	45 (65.8%)	0.228

	Do not have history of substance use other than cannabis (n = 48)	Have history of substance use other than cannabis (n = 116)	p^* * p value obtained by applying t test.
MAAS (Ave ± SD)	76.0 ± 12.8	69.6 ± 15.2	0.012

	Group Continue (n = 79)		Group Quit (n = 85)		p^* * p value obtained by applying t test.
	Ave ± SD	Median [Min – Max]	Ave ± SD	Median [Min – Max]	p^* * p value obtained by applying t test.
The characteristic of substance use	5.4 ± 0.3	5.4 [4.3 – 6.4]	4.9 ± 0.7	5.3 [2.3 – 6.9]	< 0.001
Dependency diagnosis	21.9 ± 1.8	21.5 [18 – 29]	21.1 ± 1.4	21 [13 – 23.5]	0.018
The effects of substance use on the user	26.3 ± 7.1	24 [11 – 48]	22.1 ± 4.9	20 [15 – 37]	< 0.001
Cravings	9.8 ± 2.9	9 [4 – 19]	7.7 ± 2.1	8 [4 – 13]	< 0.001
Motivation to quit using substances	11.6 ± 2.9	12 [5 – 15]	10.8 ± 3.6	12 [3 – 16]	0.216
API total	15.3 ± 2.0		13.7 ± 1.8		< 0.001
MAAS total	69.4 ± 15.3	74 [36 – 90]	78.4 ± 10.7	80 [46 – 90]	< 0.001

	^r* r* pearson correlation coefficient.	p
MAAS total	-0.456	< 0.001

	API low (n = 17)	API moderate (n = 48)	API high(n = 99)	^p* p* p value obtained by appealing Kruskal Wallis.
MAAS total Median [Min-Max]	83 [60 – 90]	81 [38 – 90]	75 [36 – 90]	< 0,001

Faculdade de Medicina da Universidade de São Paulo Rua Ovídio Pires de Campos, 785 , 05403-010 São Paulo SP Brasil, Tel./Fax: +55 11 2661-8011 - São Paulo - SP - Brazil
E-mail: archives@usp.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Address for correspondence: Salih Cihat Paltun. Ankara Numune Education and Research Hospital/Alcohol and Drug Dependence Treatment Department. Telephone: +905308205427. E-mail:drpaltun@gmail.com